cytidine monophosphate has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonosyan, MA; Bargiota, A; Bogdanski, P; Cotton, J; Czepczyński, R; Dinas, PC; Flouris, AD; Gkiata, P; Hovhannisyan, AA; Kachaev, ZM; Karabon, L; Kerchev, VV; Khachatryan, ZA; Kowalska, A; Kregielska-Narozna, M; Larina, SN; Margaryan, S; Metsios, GS; Nintou, E; Partyka, A; Pravednikova, AE; Ruchała, M; Sakellariou, P; Shidlovskii, Y; Szulinska, M; Tomkiewicz, A; Vliora, M; Witkowicz, A; Yepiskoposyan, L | 1 |
1 review(s) available for cytidine monophosphate and Metabolic Diseases
| Article | Year |
|---|---|
Prevalence of uncoupling protein one genetic polymorphisms and their relationship with cardiovascular and metabolic health.
Topics: Cardiovascular Diseases; Case-Control Studies; Cytidine Monophosphate; Genetic Predisposition to Disease; Humans; Metabolic Diseases; Polymorphism, Single Nucleotide; Prevalence; Uncoupling Protein 1 | 2022 |